MHRA Company led medicines recall: Invita D3 800IU Soft Capsules (Consilient Health UK Ltd)
CLMR number: CLMR (22)A/03
Date issued: 30th May 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for:
Invita D3 800IU Soft Capsules (Consilient Health UK Ltd)
| Batch number | Expiry Date | Pack Size | First Distributed |
| 1389492 | 31/12/2023 | 28 | 18/05/2022 |
Active ingredient: Cholecalciferol
Limited number of units from the batch were distributed prior to batch release. There are no indications of any quality of safety concerns and this recall is precautionary due to the regulatory non-compliance.
This recall is being issued as a company-led medicines recall, as this product is only supplied to several pharmacies and the company has traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
Company Contact for medical information enquiries
For medical information enquiries, please contact:
Consilient Health Pharmacovigilance and Medical Information
Email: Drugsafety@consilienthealth.com
Company Contact for stock enquiries
For stock information enquiries,
Consilient Health Customer Services Department
Email: customerservice@consilienthealth.com
To view the alert please visit the GOV.UK website.
